A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

The issuer is solely responsible for the content of this announcement.

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Republican Rep. Brandon Shippy wants to put a moratorium on mRNA vaccines, based on his ignorance about them. | Opinion ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...